S&P 500   4,562.60 (-0.10%)
DOW   36,132.43 (+0.02%)
QQQ   387.14 (-0.04%)
AAPL   192.87 (-0.28%)
MSFT   369.12 (-0.91%)
META   319.83 (+0.48%)
GOOGL   130.77 (-0.17%)
AMZN   145.95 (-0.63%)
TSLA   246.05 (+3.07%)
NVDA   462.88 (-0.60%)
NIO   8.01 (+7.81%)
BABA   72.19 (-0.26%)
AMD   119.30 (+0.78%)
T   16.99 (-1.34%)
F   10.81 (+1.98%)
MU   73.76 (+0.09%)
CGC   0.69 (+3.36%)
GE   120.69 (+0.38%)
DIS   92.04 (+1.38%)
AMC   7.01 (-0.14%)
PFE   29.12 (+0.10%)
PYPL   60.07 (+3.71%)
XOM   98.49 (-1.94%)
S&P 500   4,562.60 (-0.10%)
DOW   36,132.43 (+0.02%)
QQQ   387.14 (-0.04%)
AAPL   192.87 (-0.28%)
MSFT   369.12 (-0.91%)
META   319.83 (+0.48%)
GOOGL   130.77 (-0.17%)
AMZN   145.95 (-0.63%)
TSLA   246.05 (+3.07%)
NVDA   462.88 (-0.60%)
NIO   8.01 (+7.81%)
BABA   72.19 (-0.26%)
AMD   119.30 (+0.78%)
T   16.99 (-1.34%)
F   10.81 (+1.98%)
MU   73.76 (+0.09%)
CGC   0.69 (+3.36%)
GE   120.69 (+0.38%)
DIS   92.04 (+1.38%)
AMC   7.01 (-0.14%)
PFE   29.12 (+0.10%)
PYPL   60.07 (+3.71%)
XOM   98.49 (-1.94%)
S&P 500   4,562.60 (-0.10%)
DOW   36,132.43 (+0.02%)
QQQ   387.14 (-0.04%)
AAPL   192.87 (-0.28%)
MSFT   369.12 (-0.91%)
META   319.83 (+0.48%)
GOOGL   130.77 (-0.17%)
AMZN   145.95 (-0.63%)
TSLA   246.05 (+3.07%)
NVDA   462.88 (-0.60%)
NIO   8.01 (+7.81%)
BABA   72.19 (-0.26%)
AMD   119.30 (+0.78%)
T   16.99 (-1.34%)
F   10.81 (+1.98%)
MU   73.76 (+0.09%)
CGC   0.69 (+3.36%)
GE   120.69 (+0.38%)
DIS   92.04 (+1.38%)
AMC   7.01 (-0.14%)
PFE   29.12 (+0.10%)
PYPL   60.07 (+3.71%)
XOM   98.49 (-1.94%)
S&P 500   4,562.60 (-0.10%)
DOW   36,132.43 (+0.02%)
QQQ   387.14 (-0.04%)
AAPL   192.87 (-0.28%)
MSFT   369.12 (-0.91%)
META   319.83 (+0.48%)
GOOGL   130.77 (-0.17%)
AMZN   145.95 (-0.63%)
TSLA   246.05 (+3.07%)
NVDA   462.88 (-0.60%)
NIO   8.01 (+7.81%)
BABA   72.19 (-0.26%)
AMD   119.30 (+0.78%)
T   16.99 (-1.34%)
F   10.81 (+1.98%)
MU   73.76 (+0.09%)
CGC   0.69 (+3.36%)
GE   120.69 (+0.38%)
DIS   92.04 (+1.38%)
AMC   7.01 (-0.14%)
PFE   29.12 (+0.10%)
PYPL   60.07 (+3.71%)
XOM   98.49 (-1.94%)
Positive News SentimentPositive News

Avadel Pharmaceuticals (AVDL) News Today

$13.97
+0.22 (+1.60%)
(As of 12:45 PM ET)
Compare
Today's Range
$13.45
▼
$14.01
50-Day Range
$9.64
▼
$13.75
52-Week Range
$5.92
▼
$16.85
Volume
796,296 shs
Average Volume
710,531 shs
Market Capitalization
$1.25 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$19.50
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media
SourceHeadline
MarketBeat logoAvadel Pharmaceuticals plc (NASDAQ:AVDL) Sees Large Increase in Short Interest
americanbankingnews.com - December 1 at 4:12 AM
seekingalpha.com logoAvadel: Lumryz Lights Up The Oxybate Market, Maintaining Buy Rating
seekingalpha.com - November 14 at 4:00 PM
markets.businessinsider.com logoAnalysts’ Opinions Are Mixed on These Healthcare Stocks: Avadel Pharmaceuticals (AVDL), Zymeworks (ZYME) and Aclaris Therapeutics (ACRS)
markets.businessinsider.com - November 13 at 8:28 PM
seekingalpha.com logoAssessing Avadel's Lumryz: Clinical Innovation Versus Economic Realities
seekingalpha.com - November 12 at 3:02 AM
finance.yahoo.com logoAvadel Pharmaceuticals plc (NASDAQ:AVDL) Q3 2023 Earnings Call Transcript
finance.yahoo.com - November 10 at 1:37 PM
markets.businessinsider.com logoAvadel Pharmaceuticals Receives Buy Rating: Surpassing Revenue Expectations and Showcasing Robust Financial Health
markets.businessinsider.com - November 10 at 8:37 AM
markets.businessinsider.com logoAvadel Pharmaceuticals Sees Robust Uptake For Its Newly Approved Sleep Disorder Drug
markets.businessinsider.com - November 8 at 5:32 PM
marketwatch.com logoAvadel Pharmaceuticals ADRs Rise 19% on 3Q Revenue Growth of Lumryz Sales
marketwatch.com - November 8 at 12:32 PM
finance.yahoo.com logoAvadel Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2023 Financial Results
finance.yahoo.com - November 8 at 7:32 AM
morningstar.com logoAvadel Pharmaceuticals PLC ADR AVDL
morningstar.com - November 8 at 2:26 AM
finance.yahoo.com logoAvadel Pharmaceuticals to Provide a Corporate Update and Report Third Quarter Financial Results on November 8
finance.yahoo.com - October 30 at 1:03 PM
finance.yahoo.com logoAvadel Pharmaceuticals Announces Data Supporting Clinical Profile for LUMRYZ™ (sodium oxybate) for extended-release oral suspension (CIII) at World Sleep 2023
finance.yahoo.com - October 20 at 9:28 AM
finance.yahoo.com logoAvadel Pharmaceuticals to Present at the Jefferies Biotech CNS/Neuro Summit
finance.yahoo.com - October 5 at 9:04 AM
finance.yahoo.com logoAvadel Pharmaceuticals PLC (AVDL): Is It Really Priced Right? An In-depth Exploration
finance.yahoo.com - September 26 at 3:30 PM
markets.businessinsider.com logoWhere Avadel Pharmaceuticals Stands With Analysts
markets.businessinsider.com - September 25 at 12:58 PM
marketbeat.com logoAvadel Pharmaceuticals' (AVDL) "Buy" Rating Reaffirmed at Needham & Company LLC
marketbeat.com - September 25 at 8:17 AM
finance.yahoo.com logoAvadel Pharmaceuticals plc's (NASDAQ:AVDL) institutional investors lost 7.6% last week but have benefitted from longer-term gains
finance.yahoo.com - September 23 at 3:06 PM
marketbeat.com logoAvadel Pharmaceuticals plc (NASDAQ:AVDL) Short Interest Down 15.3% in August
marketbeat.com - September 17 at 8:20 AM
marketbeat.com logoAvadel Pharmaceuticals plc (NASDAQ:AVDL) Receives Average Rating of "Buy" from Analysts
marketbeat.com - September 17 at 2:15 AM
marketbeat.com logoOppenheimer & Co. Inc. Invests $214,000 in Avadel Pharmaceuticals plc (NASDAQ:AVDL)
marketbeat.com - September 1 at 5:25 AM
msn.com logoUnusual Call Option Trade in Avadel Pharmaceuticals plc - ADR (AVDL) Worth $625.00K
msn.com - August 22 at 11:11 PM
msn.com logoAvadel Pharmaceuticals: A Resilient Buy; A Comprehensive Assessment Of Potential Prospects
msn.com - August 22 at 7:35 AM
marketbeat.com logoHC Wainwright Weighs in on Avadel Pharmaceuticals plc's Q3 2023 Earnings (NASDAQ:AVDL)
marketbeat.com - August 14 at 2:46 AM
finance.yahoo.com logoGeoffrey Glass Bought 13% More Shares In Avadel Pharmaceuticals
finance.yahoo.com - August 13 at 5:45 PM
finance.yahoo.com logoInvesting in Avadel Pharmaceuticals (NASDAQ:AVDL) five years ago would have delivered you a 182% gain
finance.yahoo.com - August 11 at 7:01 PM
marketbeat.com logoAvadel Pharmaceuticals plc (NASDAQ:AVDL) Director Buys $187,600.00 in Stock
marketbeat.com - August 11 at 4:25 PM
marketbeat.com logoAvadel Pharmaceuticals plc (NASDAQ:AVDL) Expected to Earn FY2025 Earnings of $0.88 Per Share
marketbeat.com - August 11 at 1:16 PM
marketbeat.com logoAvadel Pharmaceuticals (NASDAQ:AVDL) Shares Gap Up on Insider Buying Activity
marketbeat.com - August 11 at 10:55 AM
msn.com logoPiper Sandler Maintains Avadel Pharmaceuticals plc - ADR (AVDL) Overweight Recommendation
msn.com - August 10 at 6:02 PM
markets.businessinsider.com logoH.C. Wainwright Reaffirms Their Buy Rating on Avadel Pharmaceuticals (AVDL)
markets.businessinsider.com - August 10 at 8:00 AM
finance.yahoo.com logoAvadel Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2023 Financial Results
finance.yahoo.com - August 9 at 10:08 AM
marketbeat.com logoAvadel Pharmaceuticals plc (NASDAQ:AVDL) is Wealth Effects LLC's Largest Position
marketbeat.com - July 31 at 11:50 AM
marketbeat.com logoSimplicity Solutions LLC Buys New Position in Avadel Pharmaceuticals plc (NASDAQ:AVDL)
marketbeat.com - July 26 at 3:47 PM
seekingalpha.com logoAvadel Pharmaceuticals: Winning Is Sweet
seekingalpha.com - July 20 at 3:26 PM
marketbeat.com logoQ2 2023 EPS Estimates for Avadel Pharmaceuticals plc (NASDAQ:AVDL) Cut by Analyst
marketbeat.com - July 7 at 7:22 AM
msn.com logoAvadel Pharmaceuticals plc - ADR (AVDL) Price Target Increased by 10.45% to 18.98
msn.com - July 6 at 8:12 PM
msn.com logoHC Wainwright & Co. Reiterates Avadel Pharmaceuticals plc - ADR (AVDL) Buy Recommendation
msn.com - July 6 at 10:11 AM
marketbeat.com logoAvadel Pharmaceuticals plc (NASDAQ:AVDL) Given Consensus Rating of "Buy" by Brokerages
marketbeat.com - July 4 at 2:17 AM
msn.com logoOppenheimer Maintains Avadel Pharmaceuticals plc - ADR (AVDL) Market Outperform Recommendation
msn.com - July 1 at 12:54 PM
marketbeat.com logoAvadel Pharmaceuticals (NASDAQ:AVDL) Shares Gap Up Following Analyst Upgrade
marketbeat.com - June 30 at 10:23 AM
markets.businessinsider.com logoLifeSci Capital Sticks to Their Buy Rating for Avadel Pharmaceuticals (AVDL)
markets.businessinsider.com - June 23 at 8:22 PM
benzinga.com logoCheck Out What Whales Are Doing With AVDL
benzinga.com - June 23 at 3:22 PM
markets.businessinsider.com logoJazz Pharmaceuticals Sues FDA Over Approval Of Rival Product, Calls It 'Unlawful'
markets.businessinsider.com - June 23 at 8:55 AM
finance.yahoo.com logoAvadel Pharmaceuticals to Host Commercial Day on June 29 for LUMRYZ™ (sodium oxybate) extended release for oral solution, CIII
finance.yahoo.com - June 22 at 8:56 AM
finance.yahoo.com logoAvadel Pharmaceuticals' Charts Are Pointed Higher
finance.yahoo.com - June 20 at 2:43 PM
marketbeat.com logoAvadel Pharmaceuticals plc (NASDAQ:AVDL) Short Interest Update
marketbeat.com - June 16 at 1:55 AM
finance.yahoo.com logoAvadel Pharmaceuticals Sponsors the Academy of Sleep Medicine Foundation’s 2023 Young Investigators Research Forum
finance.yahoo.com - June 14 at 8:06 AM
finance.yahoo.com logoAvadel Pharmaceuticals Announces Publication of Study Data in Advances in Therapy Highlighting Need for Once-at-Bedtime Oxybate Dosing for Narcolepsy
finance.yahoo.com - June 13 at 5:06 PM
finance.yahoo.com logoAvadel Pharmaceuticals Announces Publication of Study Data in Advances in Therapy Highlighting Need for Once-at-Bedtime Oxybate Dosing for Narcolepsy
finance.yahoo.com - June 13 at 5:06 PM
msn.com logoOppenheimer Reiterates Avadel Pharmaceuticals plc - ADR (AVDL) Outperform Recommendation
msn.com - June 13 at 1:36 AM
Get Avadel Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for AVDL and its competitors with MarketBeat's FREE daily newsletter.



AVDL Media Mentions By Week

AVDL Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

AVDL
News Sentiment
▼
1.91

0.43
▲
Average
Medical
News Sentiment

AVDL News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

AVDL Articles
This Week
▼
1

2
▲
AVDL Articles
Average Week

Get Avadel Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for AVDL and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

Related Companies:
Headlines Tools:
This page (NASDAQ:AVDL) was last updated on 12/6/2023 by MarketBeat.com Staff

My Account -